Announcements Trials
Browse Landscape

Phase

Phase NA 16Phase 2 8Phase 3 3Phase EARLY_PHASE1 1Phase 1 1

Status

Unknown 1Terminated 1Recruiting 1

Sponsor Class

OTHER 2NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Periampullary Cancer 1Pancreatic Neoplasms 1Pancreatic Ductal Adenocarcinoma 1Adenocarcinoma 1

Interventions

Cisplatin 726Carboplatin 609Paclitaxel 579Cyclophosphamide 516Radiotherapy 511Docetaxel 477Fluorouracil 454Gemcitabine 438Doxorubicin 383Capecitabine 361Dexamethasone 328Oxaliplatin 289pembrolizumab 283Leucovorin 283Bevacizumab 275Etoposide 272Vincristine 270Rituximab 246Prednisone 223Pemetrexed 217Cytarabine 205Drug Therapy 194Trastuzumab 176Irinotecan 174Methotrexate 171Lenalidomide 137Nivolumab 136Filgrastim 135Epirubicin 129Tamoxifen 128

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Pancreaticoduodenectomy × Clear all
NCT05843877 2026-01-30

XandTX

Technische Universität Dresden

Phase 3 Recruiting
32 enrolled
Gastrointestinal

Periampullary Cancer

NCT03317886 2017-10-24

Mesenteric Approach vs. Conventional Approach for Pancreatic Cancer

Wakayama Medical University

Phase 3 Unknown
354 enrolled
Gastrointestinal

Pancreatic Ductal Adenocarcinoma

NCT01419002 2015-07-29

Net-Pac

CHIR-Net

Phase 3 Terminated
5 enrolled
Gastrointestinal

Adenocarcinoma, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡